CT-179 is an OLIG2 inhibitor with brain permeability and oral availability. CT-179 inhibits its transcriptional activity by disrupting OLIG2 dimerization, phosphorylation, and DNA binding. CT-179 induces G2/M phase arrest, promotes apoptosis, and differentiation in tumor cells. CT-179 can be used for cancer research[1].
Molecular Weight:
397.30
Purity:
99.61
CAS Number:
[1996636-69-1]
Formula:
C17H22Cl2N6O
Target:
Apoptosis,OLIG2
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
